TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16897026
Drug: Active integration
Normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Active integration in treatment decisions
Study: 2037541
Drug: Amphotericin B
Normalized name: Amphotericin B
DrugBank: Amphotericin B (DB00681)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Amphotericin B (200 mg four times daily)
Study: 1849810
Drug: Serotonin highest
Normalized name: serotonin
DrugBank: Serotonin (DB08839)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Serotonin highest dose
Study: 28067718
Drug: CYD-TDV administered
Normalized name: dengue virus live antigen, CYD serotype 1 / dengue virus live antigen, CYD serotype 2 / dengue virus live antigen, CYD serotype 3 / dengue virus live antigen, CYD serotype 4 Injection [Dengvaxia]
Approvals — FDA: no, EMA: no, PMDA: no
Description: CYD-TDV administered as a 3-dose schedule
Study: 26232126
Drug: Probiotic milk
Normalized name: PROBIOTIC
DrugBank: Bifidobacterium longum (DB19248)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Probiotic milk containing Lactobacillus rhamnosos GG, L. acidophilus La‐5, and Bifidobacterium animalis subsp. lactis Bb‐12
Study: 20643863
Drug: Single-agent PLD
Normalized name: pLDLR-Neo
Approvals — FDA: no, EMA: no, PMDA: no
Description: Single-agent PLD
Study: 25801797
Drug: Velaglucerase alfa
Normalized name: Velaglucerase alfa
DrugBank: Velaglucerase alfa (DB06720)
Approvals — FDA: yes, EMA: yes, PMDA: no
Description: Velaglucerase alfa intravenous infusions at 60 U/kg every other week for 1.2-4.8 years
Study: 25801797
Drug: Velaglucerase alfa
Normalized name: Velaglucerase alfa
DrugBank: Velaglucerase alfa (DB06720)
Approvals — FDA: yes, EMA: yes, PMDA: no
Description: Velaglucerase alfa intravenous infusions
Study: 14663474
Drug: Finasteride 5
Normalized name: finasteride 5 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Finasteride 5 mg once daily
Study: 25056655
Drug: Yogurt containing
Normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
Approvals — FDA: no, EMA: no, PMDA: no
Description: Yogurt containing polydextrose, L. acidophilus NCFM, and B. lactis HN019 (Treatment Group)
Study: 19181414
Drug: Behavioural medicine
Normalized name: Medicaine Sting
Approvals — FDA: no, EMA: no, PMDA: no
Description: Behavioural medicine intervention
Study: 17065180
Drug: Trimetazidine (TMZ)
Normalized name: trimetazidine
DrugBank: Trimetazidine (DB09069)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Trimetazidine (TMZ) and isotonic saline infusion
Study: 23754631
Drug: 1 g
Normalized name: Molds 1 g
Approvals — FDA: no, EMA: no, PMDA: no
Description: 1 g Spirulina (Arthrospira platensis) per day for 12 weeks
Study: 16202854
Drug: Enalapril (E)
DrugBank: Enalapril (DB00584)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Enalapril (E) 10 mg
Study: 17907081
Drug: Cytostatic therapy
Normalized name: Monistat Simple Therapy
Approvals — FDA: no, EMA: no, PMDA: no
Description: Cytostatic therapy
Study: 26746199
Drug: General response
Normalized name: Besponsa
DrugBank: Inotuzumab ozogamicin (DB05889)
Approvals — FDA: yes, EMA: yes, PMDA: yes
Description: General response to fluoride treatments
Study: 24141646
Drug: Paracetamol 1
Normalized name: Paracetamol 1 g oral tablet
Approvals — FDA: no, EMA: no, PMDA: no
Description: Paracetamol 1 g
Study: 25223711
Drug: Fresh pomegranate
Normalized name: Pomegranate
DrugBank: Pomegranate (DB14317)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Fresh pomegranate juice (PJ), 1.5 mL per kg body weight
Study: 30881102
Drug: Oliceridine 0.35
Approvals — FDA: no, EMA: no, PMDA: no
Description: Oliceridine 0.35 mg
Study: 28341415
Drug: Standard diuretic
Approvals — FDA: no, EMA: no, PMDA: no
Description: Standard diuretic strategy
Study: 9735662
Drug: Specific IgE
Normalized name: BSA specific IgE
Approvals — FDA: no, EMA: no, PMDA: no
Description: Specific IgE (slgE) antibodies
Study: 9735662
Drug: Specific IgG4
Normalized name: PACIFIC OYSTER
Approvals — FDA: no, EMA: no, PMDA: no
Description: Specific IgG4 (slgG4) antibodies
Study: 396656
Drug: Pirenzepine (PRZ)
Normalized name: pirenzepine
DrugBank: Pirenzepine (DB00670)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Pirenzepine (PRZ) 150 mg daily
Study: 30294552
Drug: Insulin pump
Normalized name: insulin pump syringe
Approvals — FDA: no, EMA: no, PMDA: no
Description: Insulin pump therapy
Study: 2137901
Drug: 6 g
Normalized name: FAPi-46 GA-68
DrugBank: FAPi-46 GA-68 (DB18827)
Approvals — FDA: no, EMA: no, PMDA: no
Description: 6 g per day of corn oil
Study: 16963663
Drug: Unfractionated heparin
Normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Unfractionated heparin (IV administration)
Study: 20966402
Drug: Moderate or
Normalized name: Medicated Pad or Tape
Approvals — FDA: no, EMA: no, PMDA: no
Description: Moderate or intensive statin therapy
Study: 9669459
Drug: Control group
Normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
Approvals — FDA: no, EMA: no, PMDA: no
Description: Control group (no saliva stimulants)
Study: 28533290
Drug: Chondroitin sulfate
Normalized name: Chondroitin Sulfate
DrugBank: Chondroitin sulfate (DB09301)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Chondroitin sulfate 800 mg/day
Study: 11097665
Drug: Epidural injection
Normalized name: Sufentanil Citrate 50 ug in 1 mL EPIDURAL INJECTION
Approvals — FDA: no, EMA: no, PMDA: no
Description: Epidural injection of 10 mL saline
Study: 30517252
Drug: 2 g
Normalized name: Molds 2 g
Approvals — FDA: no, EMA: no, PMDA: no
Description: 2 g of magnesium sulfate during the induction of anesthesia
Study: 26423618
Drug: 3.6 mg
Normalized name: menthol 3.6 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: 3.6 mg pegteograstim
Study: 22674719
Drug: sulfaphenazole +
Normalized name: Sulfathiazole
DrugBank: Sulfathiazole (DB06147)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: sulfaphenazole + l‐NAME
Study: 31980978
Drug: Dotinurad 2
Normalized name: Dotinurad
DrugBank: Dotinurad (DB16145)
Approvals — FDA: no, EMA: no, PMDA: yes
Description: Dotinurad 2 mg
Study: 30371826
Drug: Cognitive Behavioral
Normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
Approvals — FDA: no, EMA: no, PMDA: no
Description: Cognitive Behavioral Treatment + Contingency Management (CBT + CM)
Study: 18385595
Drug: Control group
Normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
Approvals — FDA: no, EMA: no, PMDA: no
Description: Control group (Morphine PCA without Naloxone)
Study: 1483879
Drug: 4 mL
Normalized name: ethanol 1.4 ML/ML
Approvals — FDA: no, EMA: no, PMDA: no
Description: 4 mL hyperbaric tetracaine
Study: 21876297
Drug: Ultrasound (US)
Normalized name: ULTRASOUND
Approvals — FDA: no, EMA: no, PMDA: no
Description: Ultrasound (US) treatment with continuous wave of 1.5w/cm² for 10 minutes before stretching
Study: 3470899
Drug: Combination of
Normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
Approvals — FDA: no, EMA: no, PMDA: no
Description: Combination of hexetidine and zinc ions
Study: 394563
Drug: Intramuscular injection
Normalized name: rabies, intramuscular injection
Approvals — FDA: no, EMA: no, PMDA: no
Description: Intramuscular injection of estradiol (10 mg) and testosterone (200 mg) esters administered immediately after delivery
Study: 21851299
Drug: Infected with
Normalized name: human sputum, Bordetella pertussis infected
Approvals — FDA: no, EMA: no, PMDA: no
Description: Infected with 1.5 x 10^9 cfu M. haemolytica in 5 mL sterile nutrient broth
Study: 16704735
Drug: Artemether-lumefantrine (AL)
Normalized name: ARTEMETHER/LUMEFANTRINE
DrugBank: Lumefantrine co-artemether (DB13085)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Artemether-lumefantrine (AL) - 6-dose course (20/120 mg tablets) over three days
Study: 3135144
Drug: 300 mg
Normalized name: rutin 300 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: 300 mg oral lithium carbonate load (8.1 mmol of elemental lithium)
Study: 17049927
Drug: Treatment with
Normalized name: Campho-Phenique Cold Sore Treatment with Drying Action
Approvals — FDA: no, EMA: no, PMDA: no
Description: Treatment with counseling as usual (TAU)
Study: 9549636
Drug: Riluzole 75
Normalized name: Riluzole
DrugBank: Riluzole (DB00740)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Riluzole 75 mg twice daily
Study: 9549636
Drug: Multiple-dose administration
Normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Multiple-dose administration of riluzole
Study: 23620938
Drug: Fire needle
Normalized name: Fire Out
DrugBank: Menthol (DB14123)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Fire needle combined with narrow band ultraviolet-B (NB-UVB) therapy
Study: 23620938
Drug: Narrow band
Normalized name: Band-Aid Hurt-Free
Approvals — FDA: no, EMA: no, PMDA: no
Description: Narrow band ultraviolet-B (NB-UVB) therapy
Study: 31608930
Drug: Ghrelin infusion
Normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Ghrelin infusion
Study: 20393175
Drug: Azathioprine monotherapy
Normalized name: Azathioprine
DrugBank: Azathioprine (DB00993)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Azathioprine monotherapy
Study: 19258524
Drug: Ibuprofen (IBU)
Normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Ibuprofen (IBU) 12.5 mg/kg
Study: 29663320
Drug: Direct-to-implant breast
Normalized name: chicken breast preparation
Approvals — FDA: no, EMA: no, PMDA: no
Description: Direct-to-implant breast reconstruction with acellular dermal matrix (ADM)
Study: 30232048
Drug: GFF MDI
Normalized name: MDI-P
DrugBank: 3,4-Methylenedioxy-N-isopropylamphetamine (DB06112)
Approvals — FDA: no, EMA: no, PMDA: no
Description: GFF MDI (glycopyrrolate/formoterol fumarate metered‐dose inhaler 18/9·6 μg)
Study: 25487708
Drug: SIRT +
Normalized name: Sirturo
DrugBank: Bedaquiline (DB08903)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: SIRT + mFOLFOX6 (with a reduced dose of oxaliplatin in cycles 1-3 following SIRT)
Study: 8546909
Drug: Granisetron 40
Normalized name: Granisetron
DrugBank: Granisetron (DB00889)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Granisetron 40 micrograms kg‐1 intravenously (i.v.) on day 1, dexamethasone 20 mg i.v. on days 2 and 3 and prochlorperazine 5 mg orally thrice daily on days 1‐5
Study: 1180955
Drug: Oral prostaglandin
Normalized name: Prostaglandin D2
DrugBank: Prostaglandin D2 (DB02056)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Oral prostaglandin E2 tablets 0.5 mg hourly
Study: 18403419
Drug: Flexible GnRH
Normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Flexible GnRH antagonist protocol
Study: 16476256
Drug: PUVA baths
Normalized name: colloidal oatmeal
DrugBank: Colloidal oatmeal (DB11286)
Approvals — FDA: no, EMA: no, PMDA: no
Description: PUVA baths (photosensitizer 8‐methoxypsoralen at a concentration of 2.6 mg/l)
Study: 18192785
Drug: Acyclovir 400
Normalized name: acyclovir 400 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Acyclovir 400 mg twice daily
Study: 16909787
Drug: Treatment for
Normalized name: Hair Regrowth Treatment For Men
DrugBank: Minoxidil (DB00350)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Treatment for neuroborreliosis
Study: 31248950
Drug: Esaxerenone 5
Normalized name: Esaxerenone
DrugBank: Esaxerenone (DB15207)
Approvals — FDA: no, EMA: no, PMDA: yes
Description: Esaxerenone 5 mg/d
Study: 15131541
Drug: tenectaplase monotherapy
Normalized name: Tenecteplase
DrugBank: Tenecteplase (DB00031)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: tenectaplase monotherapy
Study: 17875198
Drug: Doubling the
Normalized name: THE-630
DrugBank: THE-630 (DB16750)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Doubling the proton pump inhibitor dose
Study: 6215443
Drug: Both drug
Normalized name: Bothrops atrox venom
Approvals — FDA: no, EMA: no, PMDA: no
Description: Both drug groups
Study: 15821526
Drug: Trospium chloride
Normalized name: Trospium Chloride
DrugBank: Trospium (DB00209)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Trospium chloride 20 mg tablets
Study: 12819976
Drug: Control group
Normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
Approvals — FDA: no, EMA: no, PMDA: no
Description: Control group (no photodynamic therapy)
Study: 29420600
Drug: Ambient precipitation
Normalized name: Precipitated Sulfur
Approvals — FDA: no, EMA: no, PMDA: no
Description: Ambient precipitation treatment
Study: 1833105
Drug: Fish oil
Normalized name: Fish oil
DrugBank: Fish oil (DB13961)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Fish oil extract (total EPA dose of 2.4 g/day) for 6 weeks
Study: 17531002
Drug: Bivalent gp120
Normalized name: L1 protein, human papillomavirus type 16 vaccine
DrugBank: Human papillomavirus type 16 L1 capsid protein antigen (DB10301)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Bivalent gp120 vaccine
Study: 10811335
Drug: Wheat bran
Normalized name: Wheat bran
DrugBank: Wheat bran (DB10685)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Wheat bran 20 g/day
Study: 506799
Drug: Glucocorticoid administration
Normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Glucocorticoid administration for 24 hours during phenformin treatment
Study: 27615436
Drug: Naftopidil 75
Normalized name: Naftopidil
DrugBank: Naftopidil (DB12092)
Approvals — FDA: no, EMA: no, PMDA: yes
Description: Naftopidil 75 mg per day
Study: 2096482
Drug: Thymus gland
Normalized name: thymus gland
Approvals — FDA: no, EMA: no, PMDA: no
Description: Thymus gland preparations (Thymu‐Skin)
Study: 2557268
Drug: Beta-blocker atenolol
Normalized name: Atenolol
DrugBank: Atenolol (DB00335)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Beta-blocker atenolol
Study: 8993958
Drug: Cetirizine 20
Normalized name: cetirizine 20 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Cetirizine 20 mg/day
Study: 1287614
Drug: Cefaclor AF
Normalized name: Cefaclor
DrugBank: Cefaclor (DB00833)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Cefaclor AF 750 mg twice daily
Study: 2992839
Drug: Nedocromil sodium
Normalized name: Nedocromil Sodium
DrugBank: Nedocromil (DB00716)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Nedocromil sodium (2 mg and 4 mg)
Study: 17070426
Drug: Angiotensin II
Normalized name: Angiotensin II
DrugBank: Angiotensin II (DB11842)
Approvals — FDA: yes, EMA: yes, PMDA: no
Description: Angiotensin II receptor antagonist therapy in echo group
Study: 11420773
Drug: 1 mg
Normalized name: biotin 1 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: 1 mg estradiol‐17 beta with cyclical dydrogesterone
Study: 3936081
Drug: Citalopram 5
Normalized name: escitalopram 5 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Citalopram 5 mg
Study: 23261048
Drug: 5-valent oral
Normalized name: L1 protein, human papillomavirus type 31 vaccine
DrugBank: Human papillomavirus type 31 L1 capsid protein antigen (DB10310)
Approvals — FDA: no, EMA: no, PMDA: no
Description: 5-valent oral rotavirus vaccine (3 doses)
Study: 21437317
Drug: Active after-sun
Normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Active after-sun (AS) lotion containing DNA-repair enzymes (photolyase from Anacystis nidulans and Micrococcus luteus extract with endonuclease activity)
Study: 29319935
Drug: Tablet A
Normalized name: tablet administration aid
Approvals — FDA: no, EMA: no, PMDA: no
Description: Tablet A (50 mg)
Study: 29319935
Drug: Tablet B
Normalized name: Biaxin 4 Tablet Blister Pack
Approvals — FDA: no, EMA: no, PMDA: no
Description: Tablet B (50 mg)
Study: 1857725
Drug: Low-Calcium diet
Normalized name: Dianeal Low Calcium 1.5
Approvals — FDA: no, EMA: no, PMDA: no
Description: Low-Calcium diet (163 +/- 1 mg/day)
Study: 23375965
Drug: 0.2 g
Normalized name: methionine 0.2 gram ORAL CAPSULE
Approvals — FDA: no, EMA: no, PMDA: no
Description: 0.2 g intravenous immunoglobulin per kg every 4 weeks
Study: 25411597
Drug: Ipragliflozin 100
Normalized name: BEXAGLIFLOZIN
DrugBank: Bexagliflozin (DB12236)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Ipragliflozin 100 mg
Study: 11320385
Drug: Vi-rEPA vaccine
Normalized name: Typhoid Vi polysaccharide vaccine
DrugBank: Typhoid Vi polysaccharide vaccine (DB10803)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Vi-rEPA vaccine (1 injection)
Study: 11320385
Drug: Vi-rEPA vaccine
Normalized name: Typhoid Vi polysaccharide vaccine
DrugBank: Typhoid Vi polysaccharide vaccine (DB10803)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Vi-rEPA vaccine
Study: 7298477
Drug: Immediate treatment
Normalized name: Hongo Killer Treatment
Approvals — FDA: no, EMA: no, PMDA: no
Description: Immediate treatment
Study: 8835624
Drug: Intravenous atropine
Normalized name: Atropine
DrugBank: Atropine (DB00572)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Intravenous atropine (0.03 mg/kg i.v.)
Study: 19643983
Drug: Subcutaneous alemtuzumab
Normalized name: Alemtuzumab
DrugBank: Alemtuzumab (DB00087)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Subcutaneous alemtuzumab
Study: 21615691
Drug: Ketorolac 20
Normalized name: ketorolac 20 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Ketorolac 20 mg
Study: 31522153
Drug: Combined orthodontic
Normalized name: combinations
Approvals — FDA: no, EMA: no, PMDA: no
Description: Combined orthodontic regenerative therapy with laser irradiation (Group I: test group)
Study: 10094221
Drug: Suplatast tosilate
Normalized name: Edoxaban Tosylate
Approvals — FDA: no, EMA: no, PMDA: no
Description: Suplatast tosilate and bufexamac ointment
Study: 30998747
Drug: 81mg of
Normalized name: Oil of peppermint
DrugBank: Peppermint oil (DB11198)
Approvals — FDA: no, EMA: no, PMDA: no
Description: 81mg of aspirin + 400mcg of folic acid
Study: 8556568
Drug: Fluticasone propionate
Normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
Approvals — FDA: yes, EMA: yes, PMDA: yes
Description: Fluticasone propionate aqueous nasal spray (FPANS)
Study: 15121266
Drug: Low-dose midazolam
Normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Low-dose midazolam with propofol (0.03 mg/kg midazolam + 0.7 mg/kg bolus propofol + 2 mg/kg/h propofol infusion)
Study: 15121266
Drug: Propofol alone
Normalized name: Propofol
DrugBank: Propofol (DB00818)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Propofol alone (0.7 mg/kg bolus propofol + 2 mg/kg/h propofol infusion)
Study: 9639218
Drug: 30 mg
Normalized name: agar 30 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: 30 mg intravenous dexamethasone over 36 hours
Study: 12508476
Drug: Levofloxacin 100
Normalized name: levofloxacin 100 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Levofloxacin 100 mg 3 times daily
Study: 25841133
Drug: 2500 IU
Normalized name: Vitamin A/Vitamin D 2500 IU-270 IU Oral Capsule
Approvals — FDA: no, EMA: no, PMDA: no
Description: 2500 IU heparin
Study: 9663365
Drug: Acarbose 100
Normalized name: acarbose 100 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Acarbose 100 mg plus Beano
Study: 23440660
Drug: Cynara scolymus
Normalized name: Cynara scolymus
Approvals — FDA: no, EMA: no, PMDA: no
Description: Cynara scolymus extract (600 mg/d)
Study: 2262233
Drug: Topical indomethacin
Normalized name: Indomethacin
DrugBank: Indomethacin (DB00328)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Topical indomethacin
Study: 19507410
Drug: Povidone-iodine solution
Normalized name: POVIDONE-IODINE 1 g in 100 mL TOPICAL LIQUID [Loris Povidone-Iodine Solution]
DrugBank: Povidone-iodine (DB06812)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Povidone-iodine solution
Study: 22127270
Drug: 300 mg
Normalized name: rutin 300 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: 300 mg EGCG
Study: 19409341
Drug: Headgear (HG)
Normalized name: guaifenesin / hydrocodone bitartrate Oral Solution [Hydro-Tussin HG]
Approvals — FDA: no, EMA: no, PMDA: no
Description: Headgear (HG) treatment started immediately with no other appliances used during the first 2 years
Study: 11695354
Drug: Pantoprazole 40
Normalized name: pantoprazole 40 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Pantoprazole 40 mg once daily
Study: 3109574
Drug: Intravenous sodium
Normalized name: immunoglobulins, intravenous
Approvals — FDA: no, EMA: no, PMDA: no
Description: Intravenous sodium heparin
Study: 9170398
Drug: Short-acting nifedipine
Normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Short-acting nifedipine 30 mg/d
Study: 3124604
Drug: Sucralfate 1
Normalized name: sucralfate 1 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Sucralfate 1 g
Study: 15886380
Drug: 250 mg/d
Normalized name: alpelisib 250 mg/day (200 mg x 1 and 50 mg x 1) ORAL TABLET
Approvals — FDA: no, EMA: no, PMDA: no
Description: 250 mg/d of DG-031
Study: 9792571
Drug: Nebulized budesonide
Normalized name: Budesonide
DrugBank: Budesonide (DB01222)
Approvals — FDA: yes, EMA: yes, PMDA: yes
Description: Nebulized budesonide (1, 2, and 4 mg/d)
Study: 8704419
Drug: Nourishing the
Normalized name: Lantiseptic Nourishing Skin
DrugBank: Dimethicone (DB11074)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Nourishing the Liver treatment
Study: 10977438
Drug: Oral levofloxacin
Normalized name: Levofloxacin
DrugBank: Levofloxacin (DB01137)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Oral levofloxacin
Study: 22381427
Drug: Trimetazidine (TMZ)
Normalized name: trimetazidine
DrugBank: Trimetazidine (DB09069)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Trimetazidine (TMZ) treatment
Study: 26848792
Drug: 4-week dose
Normalized name: milnacipran
DrugBank: Milnacipran (DB04896)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: 4-week dose reduction group
Study: 26215396
Drug: Normal protein
Normalized name: protein C
DrugBank: Protein C (DB11312)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Normal protein (NP) diet (2 g · kg(‐1) · d(‐1))
Study: 19020157
Drug: Tapentadol HCl
Normalized name: tapentadol HCl
DrugBank: Tapentadol (DB06204)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Tapentadol HCl 75 mg
Study: 9087161
Drug: Triamcinolone acetonide
Normalized name: Triamcinolone Acetonide
DrugBank: Triamcinolone (DB00620)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Triamcinolone acetonide nasal aerosol (220 micrograms, once daily for 6 weeks)
Study: 2868173
Drug: Antibiotic regimens
Normalized name: Anacin Aspirin Regimen Pill
Approvals — FDA: no, EMA: no, PMDA: no
Description: Antibiotic regimens for preventing or treating wound sepsis
Study: 8765813
Drug: Nebulized budesonide
Normalized name: Budesonide
DrugBank: Budesonide (DB01222)
Approvals — FDA: yes, EMA: yes, PMDA: yes
Description: Nebulized budesonide (1 mg)
Study: 22427678
Drug: Highly active
Normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Highly active antiretroviral therapy (HAART)
Study: 24315907
Drug: 5 mg
Normalized name: talc 25 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: 5 mg morphine intravenously
Study: 17393189
Drug: Oral cryotherapy
Normalized name: menthol
DrugBank: Menthol (DB14123)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Oral cryotherapy (in autologous setting)
Study: 11125386
Drug: Periurethral autologous
Normalized name: Autologous cultured fibroblasts
DrugBank: Azficel-T (DB11051)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Periurethral autologous fat injection
Study: 24649785
Drug: Theophylline 250
Normalized name: theophylline 250 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Theophylline 250 mg three times per day